SAREPTA THERAPEUTICS INC's ticker is and the CUSIP is 803607900. A total of 4 filers reported holding SAREPTA THERAPEUTICS INC in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $18,154 | -23.9% | 114,900 | -37.6% | 0.01% | -21.4% |
Q1 2024 | $23,846 | -53.5% | 184,200 | -65.4% | 0.01% | -57.6% |
Q4 2023 | $51,271 | +79.1% | 531,700 | +125.1% | 0.03% | +43.5% |
Q3 2023 | $28,632 | +23.8% | 236,200 | +17.0% | 0.02% | +21.1% |
Q2 2023 | $23,121 | -0.4% | 201,900 | +19.8% | 0.02% | -5.0% |
Q1 2023 | $23,224 | +60.6% | 168,500 | +51.0% | 0.02% | +25.0% |
Q4 2022 | $14,461 | -99.9% | 111,600 | +26.7% | 0.02% | +45.5% |
Q3 2022 | $9,738,000 | +405.6% | 88,100 | +242.8% | 0.01% | +450.0% |
Q2 2022 | $1,926,000 | -47.9% | 25,700 | -45.7% | 0.00% | -33.3% |
Q1 2022 | $3,695,000 | -61.8% | 47,300 | -55.9% | 0.00% | -70.0% |
Q4 2021 | $9,662,000 | +279.9% | 107,300 | +230.2% | 0.01% | +400.0% |
Q3 2021 | $2,543,000 | +0.0% | 32,500 | -0.6% | 0.00% | 0.0% |
Q2 2021 | $2,542,000 | – | 32,700 | +3320.5% | 0.00% | – |
Q1 2021 | $0 | -100.0% | 956 | -13.4% | 0.00% | -100.0% |
Q4 2020 | $18,822,000 | +161.3% | 1,104 | +115.2% | 0.02% | +140.0% |
Q3 2020 | $7,204,000 | -3.0% | 513 | +10.8% | 0.01% | -16.7% |
Q2 2020 | $7,423,000 | +83.3% | 463 | +11.8% | 0.01% | +71.4% |
Q1 2020 | $4,049,000 | -74.3% | 414 | -66.1% | 0.01% | -79.4% |
Q4 2019 | $15,781,000 | +217.5% | 1,223 | +85.3% | 0.03% | +142.9% |
Q3 2019 | $4,971,000 | -52.5% | 660 | -4.2% | 0.01% | -51.7% |
Q2 2019 | $10,469,000 | +57.4% | 689 | +23.5% | 0.03% | +61.1% |
Q1 2019 | $6,650,000 | -7.5% | 558 | -15.3% | 0.02% | -14.3% |
Q4 2018 | $7,191,000 | -25.4% | 659 | +10.4% | 0.02% | -32.3% |
Q3 2018 | $9,642,000 | -31.7% | 597 | -44.1% | 0.03% | -43.6% |
Q2 2018 | $14,116,000 | +3293.3% | 1,068 | +335.9% | 0.06% | +205.6% |
Q1 2018 | $416,000 | -52.9% | 245 | -63.8% | 0.02% | -52.6% |
Q4 2017 | $883,000 | -14.8% | 676 | -64.2% | 0.04% | -9.5% |
Q3 2017 | $1,036,000 | +482.0% | 1,886 | +302.1% | 0.04% | +425.0% |
Q2 2017 | $178,000 | +41.3% | 469 | -49.2% | 0.01% | +60.0% |
Q1 2017 | $126,000 | -55.3% | 924 | -65.9% | 0.01% | -70.6% |
Q4 2016 | $282,000 | -94.6% | 2,708 | -12.2% | 0.02% | -95.2% |
Q3 2016 | $5,250,000 | +437.4% | 3,083 | -13.8% | 0.36% | +447.7% |
Q2 2016 | $977,000 | +106.6% | 3,578 | +95.4% | 0.06% | +71.1% |
Q1 2016 | $473,000 | -5.2% | 1,831 | +248.1% | 0.04% | -2.6% |
Q4 2015 | $499,000 | +41.4% | 526 | -12.6% | 0.04% | +50.0% |
Q3 2015 | $353,000 | -21.4% | 602 | +16.4% | 0.03% | -31.6% |
Q2 2015 | $449,000 | +1852.2% | 517 | +154.7% | 0.04% | +1166.7% |
Q1 2015 | $23,000 | -11.5% | 203 | -66.3% | 0.00% | 0.0% |
Q4 2014 | $26,000 | – | 603 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GROUP ONE TRADING, L.P. | 297,600 | $22,415,000 | 0.18% |
SIMPLEX TRADING, LLC | 660 | $4,971,000 | 0.01% |
IMC-Chicago, LLC | 28,700 | $2,162,000 | 0.01% |
JPMORGAN CHASE & CO | 74,700 | $5,626,000 | 0.00% |
ADVENT CAPITAL MANAGEMENT /DE/ | 263 | $9,000 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |